admin_auro

December 29, 2017

Published by admin_auro at December 29, 2017

Categories

Natural product-based therapy for Metabolic diseases: A pharmaceutical mixture [PMSFN] encompassing Pyridoxamine(PM) and Sulforaphane (SFN) increases the expression of Caveolin-1, stabilizes insulin receptor, promotes insulin sensitivity, incrases vasorelaxation, and decreases the risk of hyperglycemia and TIIDM via up regulation of its target gene.., 29/December/2017, 11.01 pm

Introduction: What they say A study from the Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland shows that “MicroRNAs 103 and 107 regulate insulin sensitivity.” This study was published, in the June […]

December 28, 2017

Published by admin_auro at December 28, 2017

Categories

Natural product-derived therapy for muscle atrophy and wasting:Acacetin, isolated from Robinia pseudoacacia (black locust) and anoda cristata, among others, increases the expression of FGF19 and its receptor ß-Klotho, phosphorylates ERK1/2 and S6K1, decreases the expression of tumor suppressors genes, promotes regeneration of muscle cells and hypertrophy of skeletal muscle, and reverses muscular atrophy and wasting via up regulation of its target gene, 29/December/2017, 12.24 am

Introduction: What they say A study from Department of Biology, University of Bergen, Bergen, Norway; and Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard […]

December 28, 2017

Published by admin_auro at December 28, 2017

Categories

Combinatorial Antiviral Therapy (CAT): Amodiaquine (ADQ), an antifungal drug, inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, Influenza H1NI1, respiratory syncytical , Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 29/December/2017, 1.2.16 am

Introduction: What they say: A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA […]

December 28, 2017

Published by admin_auro at December 28, 2017

Categories

Ideas
Pain

Activation of the PD-1 pathway for Pain therapy: Diclofenac, a drug used in the treatment of osteoarthritis and migraine, increases the expression of PD-L1, attenuates acutes and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gene, 29/December/2017, 12.10 am

Introduction:What they say: A recent study, from Institute of Neurobiology, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Collaborative Innovation Center for Brain […]